News

Eli Lilly is suing two pharmacies for compounding Zepbound and Mounjaro, claiming the companies are skirting the Food and Drug Administration's ban on the practice and luring people away from ...
This is roughly $800 more than the list price Eli Lilly & Co. charges for its drug, and includes a Hims membership, unlimited consultations with a provider and treatment support, the spokesperson ...
Eli Roth‘s The Horror Section has acquired “Jimmy and Stiggs,” marking the horror company’s first major deal since launching earlier this month, Variety can exclusively report. Directed ...
Reserve your spot now. Eli Lilly And Co LLY, on Sunday, announced positive Phase 2 results for lepodisiran, an investigational small interfering RNA (siRNA) therapy designed to lower the ...
Indiana-based pharmaceutical company Eli Lilly is part of the race to slow or prevent Alzheimer's disease worldwide. One of its drugs was recently approved in the United States. But the European ...
Credit: Shutterstock / Dmytro Zinkevych. Eli Lilly has reported promising Phase II results for lepodisiran, its experimental therapy aimed at reducing lipoprotein(a) [Lp(a)], a genetically inherited ...
In a report released today, Geoff Meacham from Citi maintained a Buy rating on Eli Lilly & Co (LLY – Research Report). The company’s shares closed yesterday at $821.67. Easily identify stocks ...
This primarily relates to AWS." Turning to Alphabet, which made $52.5 billion in capital spending in 2024, its CFO Anat Ashkenazi said it planned to spend $75 billion in 2025 and "increase our ...